Mackay Shields LLC’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-47,400
Closed -$338K 1175
2021
Q1
$338K Buy
47,400
+20,200
+74% +$142K ﹤0.01% 1310
2020
Q4
$143K Buy
+27,200
New +$107K ﹤0.01% 1448
2020
Q2
Sell
-255,373
Closed -$600K 1559
2020
Q1
$600K Sell
255,373
-481,984
-65% -$3.12M 0.01% 1092
2019
Q4
$7.74M Buy
737,357
+311,292
+73% +$2.82M 0.05% 378
2019
Q3
$3.64M Buy
426,065
+187,234
+78% +$1.84M 0.02% 642
2019
Q2
$2.75M Sell
238,831
-173,434
-42% -$2.23M 0.02% 775
2019
Q1
$5.78M Sell
412,265
-170,560
-29% -$2.24M 0.04% 459
2018
Q4
$6.03M Buy
582,825
+189,692
+48% +$2.8M 0.05% 427
2018
Q3
$6.73M Sell
393,133
-100,669
-20% -$1.73M 0.05% 395
2018
Q2
$8.89M Buy
+493,802
New +$9.9M 0.06% 367

Other funds holding PTEN

Mackay Shields LLC's PTEN Position: Q2 2021 in Review

Mackay Shields LLC sold out of Patterson-UTI (PTEN) in Q2 2021, closing a stake of 47,400 shares — an estimated $338K sold.

Mackay Shields LLC first reported a position in PTEN in Q2 2018 and held it in 10 quarters. The position peaked at $8.89M in Q2 2018. 214 funds tracked by Wall St. Rank hold PTEN as of Q2 2021.

  • Mackay Shields LLC reported no remaining Patterson-UTI position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 47,400 Patterson-UTI shares in Q2 2021, an estimated $338K.
  • Mackay Shields LLC first reported a position in Patterson-UTI in Q2 2018 and held it in 10 quarters.
  • Mackay Shields LLC's Patterson-UTI position peaked at $8.89M in Q2 2018.
  • 214 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.